BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25598342)

  • 1. Gene silencing: a therapeutic approach to combat influenza virus infections.
    Khanna M; Saxena L; Rajput R; Kumar B; Prasad R
    Future Microbiol; 2015; 10(1):131-40. PubMed ID: 25598342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of siRNAs to prevent and treat influenza virus infection.
    Ge Q; Eisen HN; Chen J
    Virus Res; 2004 Jun; 102(1):37-42. PubMed ID: 15068878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential therapeutic for pandemic influenza using RNA interference.
    Seth S; Templin MV; Severson G; Baturevych O
    Methods Mol Biol; 2010; 623():397-422. PubMed ID: 20217566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.
    Liang W; Chow MY; Lau PN; Zhou QT; Kwok PC; Leung GP; Mason AJ; Chan HK; Poon LL; Lam JK
    Mol Pharm; 2015 Mar; 12(3):910-21. PubMed ID: 25599953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role and application of RNA interference in replication of influenza viruses.
    Betáková T; Svančarová P
    Acta Virol; 2013; 57(2):97-104. PubMed ID: 23600867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference strategies as therapy for respiratory viral infections.
    DeVincenzo JP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S118-22. PubMed ID: 18820571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.
    Lesch M; Luckner M; Meyer M; Weege F; Gravenstein I; Raftery M; Sieben C; Martin-Sancho L; Imai-Matsushima A; Welke RW; Frise R; Barclay W; Schönrich G; Herrmann A; Meyer TF; Karlas A
    PLoS Pathog; 2019 Mar; 15(3):e1007601. PubMed ID: 30883607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza.
    Wong JP; Christopher ME; Salazar AM; Sun LQ; Viswanathan S; Wang M; Saravolac EG; Cairns MJ
    Front Biosci (Schol Ed); 2010 Jan; 2(2):791-800. PubMed ID: 20036985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems biology of influenza: understanding multidimensional interactions for personalized prevention and treatment.
    Yan Q
    Methods Mol Biol; 2010; 662():285-302. PubMed ID: 20824477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the oligoadenylate synthetases-like protein and does it have therapeutic potential for influenza?
    Alcorn JF; Sarkar SN
    Expert Rev Respir Med; 2015 Feb; 9(1):1-3. PubMed ID: 25544107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human influenza].
    Stock I
    Med Monatsschr Pharm; 2006 Oct; 29(10):360-8; quiz 369-70. PubMed ID: 17058895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference: on the road to an alternate therapeutic strategy!
    Dave RS; Pomerantz RJ
    Rev Med Virol; 2003; 13(6):373-85. PubMed ID: 14625885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of influenza virus production in virus-infected mice by RNA interference.
    Ge Q; Filip L; Bai A; Nguyen T; Eisen HN; Chen J
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8676-81. PubMed ID: 15173599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections.
    Ludwig S
    Biol Chem; 2011 Oct; 392(10):837-47. PubMed ID: 21823902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H5N1 Avian influenza: preventive and therapeutic strategies against a pandemic.
    Sambhara S; Poland GA
    Annu Rev Med; 2010; 61():187-98. PubMed ID: 20059335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Target of developing the new anti-influenza virus reagents].
    Toyoda T
    Nihon Rinsho; 2003 Nov; 61(11):1980-6. PubMed ID: 14619442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Being prepared. Preparations for a pandemic of influenza.
    Owens SR
    EMBO Rep; 2001 Dec; 2(12):1061-3. PubMed ID: 11743013
    [No Abstract]   [Full Text] [Related]  

  • 20. New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections.
    van de Wakker SI; Fischer MJE; Oosting RS
    Eur J Pharmacol; 2017 Aug; 809():178-190. PubMed ID: 28533172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.